Thyroid hormone (T3)-modification of polyethyleneglycol (PEG)-polyethyleneimine (PEI) graft copolymers for improved gene delivery to hepatocytes.

[1]  J. Rosenecker,et al.  Interaction of polyamine gene vectors with RNA leads to the dissociation of plasmid DNA‐carrier complexes , 2006, The journal of gene medicine.

[2]  K. Millen,et al.  Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. , 2006, Endocrinology.

[3]  J. Rosenecker,et al.  Uronic acids functionalized polyethyleneimine (PEI)-polyethyleneglycol (PEG)-graft-copolymers as novel synthetic gene carriers. , 2006, Biomaterials.

[4]  Jaroslav Pelisek,et al.  Toward synthetic viruses: endosomal pH-triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  N. Ferry,et al.  Liver gene therapy: advances and hurdles , 2004, Gene therapy.

[6]  D. Fischer,et al.  Effect of poly(ethylene imine) molecular weight and pegylation on organ distribution and pharmacokinetics of polyplexes with oligodeoxynucleotides in mice. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[7]  J. Behr,et al.  A model for non‐viral gene delivery: through syndecan adhesion molecules and powered by actin , 2004, The journal of gene medicine.

[8]  A. Johansson,et al.  Non-viral delivery of the porphobilinogen deaminase cDNA into a mouse model of acute intermittent porphyria. , 2004, Molecular genetics and metabolism.

[9]  C. Densmore,et al.  Biodistribution and pharmacokinetics of aerosol and intravenously administered DNA-polyethyleneimine complexes: optimization of pulmonary delivery and retention. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  S S Gambhir,et al.  Optical imaging of transferrin targeted PEI/DNA complexes in living subjects , 2003, Gene Therapy.

[11]  R. Müller,et al.  Oligomers of the Arginine-rich Motif of the HIV-1 TAT Protein Are Capable of Transferring Plasmid DNA into Cells* 210 , 2003, The Journal of Biological Chemistry.

[12]  G. De Rosa,et al.  Spectrophotometric determination of polyethylenimine in the presence of an oligonucleotide for the characterization of controlled release formulations. , 2003, Journal of pharmaceutical and biomedical analysis.

[13]  S. Kawakami,et al.  Molecular weight-dependent gene transfection activity of unmodified and galactosylated polyethyleneimine on hepatoma cells and mouse liver. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  E. Wagner,et al.  Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice , 2002, Hepatology.

[15]  R. Müller,et al.  Nonviral gene delivery to the lung with copolymer-protected and transferrin-modified polyethylenimine. , 2002, Biochimica et biophysica acta.

[16]  E. Wagner,et al.  Tumor-targeted gene delivery of tumor necrosis factor-α induces tumor necrosis and tumor regression without systemic toxicity , 2002, Cancer Gene Therapy.

[17]  Clive J Roberts,et al.  Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. , 2002, Bioconjugate chemistry.

[18]  D. Fischer,et al.  The Structure of PEG-Modified Poly(Ethylene Imines) Influences Biodistribution and Pharmacokinetics of Their Complexes with NF-κB Decoy in Mice , 2002, Pharmaceutical Research.

[19]  S. W. Kim,et al.  A new synthesis of galactose-poly(ethylene glycol)-polyethylenimine for gene delivery to hepatocytes. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[20]  E. Wagner,et al.  Design and gene delivery activity of modified polyethylenimines. , 2001, Advanced drug delivery reviews.

[21]  T. Visser,et al.  Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. , 2001, Endocrine reviews.

[22]  S. Carotta,et al.  Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo , 2001, The journal of gene medicine.

[23]  D. Liu,et al.  Hydrodynamics-based gene delivery. , 2001, Current opinion in molecular therapeutics.

[24]  H. Cölfen,et al.  Synthesis of double-hydrophilic block copolymers with hydrophobic moieties for the controlled crystallization of minerals. , 2001 .

[25]  G. Levi,et al.  Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes , 2000, Gene Therapy.

[26]  J. Behr,et al.  Systemic linear polyethylenimine (L‐PEI)‐mediated gene delivery in the mouse , 2000, The journal of gene medicine.

[27]  J. Wolff,et al.  High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. , 1999, Human gene therapy.

[28]  C. Steer,et al.  Nucleotide Exchange in Genomic DNA of Rat Hepatocytes Using RNA/DNA Oligonucleotides , 1999, The Journal of Biological Chemistry.

[29]  M. Ogris,et al.  PEGylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery , 1999, Gene Therapy.

[30]  S. Cheng,et al.  Hormone-induced Translocation of Thyroid Hormone Receptors in Living Cells Visualized Using a Receptor Green Fluorescent Protein Chimera* , 1998, The Journal of Biological Chemistry.

[31]  J. Behr,et al.  In vitro gene delivery to hepatocytes with galactosylated polyethylenimine. , 1997, Bioconjugate chemistry.

[32]  E. Krenning,et al.  Transport of 3,5,3'-triiodothyronine into the perfused rat liver and subsequent metabolism are inhibited by fasting. , 1992, Endocrinology.

[33]  A. Pontecorvi,et al.  Differential effect of a new thyromimetic on triiodothyronine transport into myoblasts and hepatoma and neuroblastoma cells. , 1992, Biochimica et biophysica acta.

[34]  I. Pastan,et al.  Receptor-mediated uptake of 3,3',5-triiodo-L-thyronine by cultured fibroblasts. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[35]  I. Pastan,et al.  Fluorescent rhodamine‐labeled thyroid hormone derivatives , 1979, FEBS letters.

[36]  E. Wagner,et al.  Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application , 2001, Gene Therapy.

[37]  S. Ricard-Blum,et al.  Kinetics of internalization and subcellular binding sites for T3 in mouse liver , 1996, Biology of the cell.

[38]  E. Krenning,et al.  Uptake and metabolism of 3,5,3'-triiodothyronine and 3,3',5'-triiodothyronine by human liver-derived cells: HepG2 cells as a model for thyroid hormone handling by human liver. , 1996, The Journal of clinical endocrinology and metabolism.

[39]  Smoryzanova Oa,et al.  Distribution kinetics and metabolism of triiodothyronine and thyroxine in the organs and tissues of mice with transplanted Lewis carcinoma , 1985 .